Better Business Bureau

Charity Contact Information BBB Wise Giving Alliance Comments Programs

Tax Status Governance Fund Raising Financial

Name:	American Leprosy Missions
Address:	One Alm Way
	Greenville, SC 29601
Phone:	864-271-7040 800-543-3135
Web Address:	www.leprosy.org

ALM meets the 20 Standards for Charity Accountability.

ALM covers costs of treating leprosy in countries in Africa, Asia, and South America that have the highest rates of prevalence for the disease. ALM also funds reconstructive, cosmetic, and other surgical procedures to alleviate the damage from leprosy to the body, provides physical therapy rehabilitation programs, and offers patients help in starting businesses and learning job skills, supplying vocational training in areas such as carpentry or sewing. In addition to research grants aimed at improving the screening and assessment of patients, ALM is funding efforts that it hopes will lead to development of a leprosy vaccine. At ALM supported hospitals, health workers receive training in recognizing and treating leprosy. ALM also sponsors broadcasts and produces materials ranging from books and brochures to posters for health clinics that are designed to teach recognition of early warning signs as well as reduce the fear and stigma associated with leprosy. In response to a steep rise in incidences over the past decade, ALM also is carrying out a campaign against Buruli ulcer (a flesh-destroying bacterium closely related to leprosy) in Cote D'Ivoire and Ghana.

For the year ended December 31, 2009, ALM's program expenses were:

Leprosy treatment	1,126,848
Research	935,345
Prevention of disabilities	730,346
Socio-economic services	657,136
Other diseases	477,675
Training of professionals	371,204
Total Program Expenses:	$4,298,554

Chief Executive : David W. Simmons, President and CEO

Compensation*:

Chair of the Board: Mary Phillips
Chair's Profession / Business Affiliation: University Professor

Board Size: 15

Paid Staff Size: 16

*2009 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances. Prior to Mr. Simmons assuming the CEO position in December 2010, Mr. Christopher Doyle was the CEO of ALM and he was compensated $156,356 for 2009.

Method(s) Used:

Direct mail, telemarketing, print advertisements, television, grant proposals, Internet appeals, and planned giving.

Fund raising costs were 27% of related contributions. (Related contributions, which totaled $6,649,295, are donations received as a result of fund raising activities.)

This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.

The following information is based on ALM's audited financial statements for the year ended December 31, 2009.

Source of Funds
Contributions	5,407,628
Legacies and bequests	1,241,667
Income from outside trusts	132,823
Investment income, net	87,139
Other	21,603
Realized loss on investment transactions	-296,841
Total Income	$6,594,019

Uses of Funds as a % of Total Expenses

Programs: 66%  Fund Raising: 27%  Administrative: 7%

Total income				$6,594,019
	Program expenses			$4,298,554
	Fund raising expenses			1,777,740
	Administrative expenses			449,608
Total expenses				$6,525,902
Income in Excess of Expenses				68,117
Beginning net assets				10,923,612
Other Changes in Net Assets				1,598,311
Ending net assets				12,590,040
Total liabilities				863,666
Total assets				$13,453,706

Note: In the above financial summary, "other changes in net assets" includes net unrealized gains on long-term investments ($904,733), change in beneficial interest in perpetual trusts ($722,582), and actuarial loss on annuity and unitrust obligations (-$29,004).